Records containing: Overactive Bladder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-02-15Comparison of the Therapeutic Effects of Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2017-01-20NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder Symptoms
-
CLINICAL_TRIALS study record update · 2017-01-12Multicenter, Randomized, Double-blind, Parallel, Active Control, Phase III Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With Overactive Bladder Including an Open-label, Extension Study
-
CLINICAL_TRIALS study record update · 2016-12-07Biowave Overactive Bladder (OAB) Trial
-
CLINICAL_TRIALS study record update · 2016-12-07Double-blind, Randomized, Shame-controlled Multicenter Clinical Study to Evaluate Efficacy and Safety of Low-level Light Therapy Device(Color DNA-WSF) for the Treatment of Overactive Bladder and Urinary Incontinence in Women
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-06Randomized Double Blinded Placebo-controlled Trial of the Once Daily 5mg Dose of Solifenacin Succinate vs. Placebo in Inner City Women Ages 20-45 With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2016-11-21Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain
-
CLINICAL_TRIALS study record update · 2016-11-01Long-Term Specified Drug Use-results Survey of Betanis Tablets
-
CLINICAL_TRIALS study record update · 2016-10-24Do Increased Levels of Anxiety Decrease the Reproducibility of Symptoms During Urodynamic Studies in Women?
-
CLINICAL_TRIALS study record update · 2016-10-20A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2016-10-20A Single Blind, Randomised, Controlled Trial to Evaluate the Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Overactive Bladder (OAB) Symptoms in Women Responders to Posterior Tibial Nerve Stimulation (PTNS)
-
CLINICAL_TRIALS study record update · 2016-10-17A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
-
CLINICAL_TRIALS study record update · 2016-09-26A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2016-08-30A Double-Blind, Randomized Study of the Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) Versus Oral Oxybutynin in Spinal Cord Injured Patients With Neurogenic Detrusor Overactivity (Protocol Number 11-09-10-04)
-
CLINICAL_TRIALS study record update · 2016-08-09An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
-
CLINICAL_TRIALS study record update · 2016-07-21ClinicalTrials.gov study NCT02601287
-
CLINICAL_TRIALS study record update · 2016-07-20A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2016-07-19Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies
-
CLINICAL_TRIALS study record update · 2016-07-01A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Oral Administration of DA-8010 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2016-06-24Randomized, Open-label, Single Dose, Two-way Crossover, Clinical Trial to Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 After Oral Administration in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2016-06-24Clinical Trial to Investigate and Compare the Pharmacokinetic Characteristics and Safety/Tolerability After Single Administration of JLP-1207 and Soifenacin/Tamsulosin in Healthy Male Volunteers.
-
CLINICAL_TRIALS study record update · 2016-06-24Pharmacokinetic Drug Interaction Between Solifenacin 10mg and Tamsulosin 0.4mg in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2016-06-22A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency
-
CLINICAL_TRIALS study record update · 2016-06-03Single Centre Randomised Pilot Study of Two Regimens (30mins Daily or Weekly for 12 Weeks) of Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome
-
CLINICAL_TRIALS study record update · 2016-05-26A Placebo Controlled Randomized, 12-week, Dose-ranging, Double-blind Study Versus Placebo Using Tolterodine as a Study Calibrator, to Evaluate Efficacy and Safety of SSR240600C in Women With Overactive Bladder Including Urge Urinary Incontinence